177 related articles for article (PubMed ID: 9157961)
1. Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL: relevance to the inflammatory phase of atherogenesis.
Stengel D; Antonucci M; Arborati M; Hourton D; Griglio S; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):954-62. PubMed ID: 9157961
[TBL] [Abstract][Full Text] [Related]
2. Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity.
Hourton D; Stengel D; Chapman MJ; Ninio E
Eur J Biochem; 2001 Aug; 268(16):4489-96. PubMed ID: 11502209
[TBL] [Abstract][Full Text] [Related]
3. Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages.
Hourton D; Delerive P; Stankova J; Staels B; Chapman MJ; Ninio E
Biochem J; 2001 Feb; 354(Pt 1):225-32. PubMed ID: 11171098
[TBL] [Abstract][Full Text] [Related]
4. Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: relevance to progression of atherosclerosis.
Brochériou I; Stengel D; Mattsson-Hultén L; Stankova J; Rola-Pleszczynski M; Koskas F; Wiklund O; Le Charpentier Y; Ninio E
Circulation; 2000 Nov; 102(21):2569-75. PubMed ID: 11085958
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism.
Frostegård J; Huang YH; Rönnelid J; Schäfer-Elinder L
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):963-8. PubMed ID: 9157962
[TBL] [Abstract][Full Text] [Related]
6. Agonist-induced down-regulation of platelet-activating factor receptor gene expression in U937 cells.
Chau LY; Peck K; Yen HH; Wang JY
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):911-6. PubMed ID: 7519853
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte/macrophage-like U937 cells.
Korth R; Zimmermann K; Richter WO
Chem Phys Lipids; 1994 Apr; 70(2):109-19. PubMed ID: 8033283
[TBL] [Abstract][Full Text] [Related]
8. Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis.
Dentan C; Lesnik P; Chapman MJ; Ninio E
Eur J Biochem; 1996 Feb; 236(1):48-55. PubMed ID: 8617285
[TBL] [Abstract][Full Text] [Related]
9. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects.
Verouti SN; Fragopoulou E; Karantonis HC; Dimitriou AA; Tselepis AD; Antonopoulou S; Nomikos T; Demopoulos CA
Atherosclerosis; 2011 Dec; 219(2):519-25. PubMed ID: 21920519
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids.
Chang PY; Luo S; Jiang T; Lee YT; Lu SC; Henry PD; Chen CH
Circulation; 2001 Jul; 104(5):588-93. PubMed ID: 11479258
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced up-regulation of platelet-activating factor receptor messenger RNA in human monocytes.
Shirasaki H; Adcock IM; Kwon OJ; Nishikawa M; Mak JC; Barnes PJ
Eur J Pharmacol; 1994 Jul; 268(2):263-6. PubMed ID: 7957648
[TBL] [Abstract][Full Text] [Related]
12. Oxidised LDL decreases VEGFR-1 expression in human monocyte-derived macrophages.
Salomonsson L; Svensson L; Pettersson S; Wiklund O; Ohlsson BG
Atherosclerosis; 2003 Aug; 169(2):259-67. PubMed ID: 12921977
[TBL] [Abstract][Full Text] [Related]
13. Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation.
Rios FJ; Koga MM; Ferracini M; Jancar S
PLoS One; 2012; 7(5):e36632. PubMed ID: 22570732
[TBL] [Abstract][Full Text] [Related]
14. Degree of oxidation of low density lipoprotein affects expression of CD36 and PPARgamma, but not cytokine production, by human monocyte-macrophages.
Kavanagh IC; Symes CE; Renaudin P; Nova E; Mesa MD; Boukouvalas G; Leake DS; Yaqoob P
Atherosclerosis; 2003 Jun; 168(2):271-82. PubMed ID: 12801610
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells.
Fragopoulou E; Iatrou C; Antonopoulou S; Ruan XZ; Fernando RL; Powis SH; Moorhead JF; Varghese Z
J Lab Clin Med; 2006 Jun; 147(6):281-9. PubMed ID: 16750665
[TBL] [Abstract][Full Text] [Related]
16. Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor.
Lehr HA; Seemüller J; Hübner C; Menger MD; Messmer K
Arterioscler Thromb; 1993 Jul; 13(7):1013-8. PubMed ID: 8391309
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine.
Stengel D; Antonucci M; Gaoua W; Dachet C; Lesnik P; Hourton D; Ninio E; Chapman MJ; Griglio S
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1172-80. PubMed ID: 9672079
[TBL] [Abstract][Full Text] [Related]
18. Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages.
Rios FJ; Gidlund M; Jancar S
Cell Physiol Biochem; 2011; 27(3-4):363-72. PubMed ID: 21471725
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth.
Ibe BO; Sander FC; Raj JU
Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1168-76. PubMed ID: 10749711
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1.
Proudfoot JM; Croft KD; Puddey IB; Beilin LJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):846-53. PubMed ID: 12626661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
